Vertex Pharmaceuticals Inc (VRTX)
418.01
+0.69
(+0.17%)
USD |
NASDAQ |
Mar 28, 16:00
418.39
+0.38
(+0.09%)
After-Hours: 20:00
Vertex Pharmaceuticals Free Cash Flow (Quarterly): 118.50M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 118.50M |
September 30, 2023 | 1.228B |
June 30, 2023 | 1.075B |
March 31, 2023 | 857.80M |
December 31, 2022 | 1.045B |
September 30, 2022 | 901.30M |
June 30, 2022 | 1.086B |
March 31, 2022 | 892.60M |
December 31, 2021 | 933.20M |
September 30, 2021 | 874.80M |
June 30, 2021 | -249.60M |
March 31, 2021 | 850.10M |
December 31, 2020 | 443.84M |
September 30, 2020 | 732.95M |
June 30, 2020 | 1.021B |
March 31, 2020 | 796.25M |
December 31, 2019 | 429.27M |
September 30, 2019 | 310.50M |
June 30, 2019 | 447.39M |
March 31, 2019 | 306.74M |
December 31, 2018 | 298.93M |
September 30, 2018 | 360.44M |
June 30, 2018 | 292.09M |
March 31, 2018 | 223.38M |
December 31, 2017 | 184.53M |
Date | Value |
---|---|
September 30, 2017 | -17.87M |
June 30, 2017 | 164.28M |
March 31, 2017 | 254.59M |
December 31, 2016 | 129.94M |
September 30, 2016 | 51.77M |
June 30, 2016 | 24.94M |
March 31, 2016 | -27.11M |
December 31, 2015 | 16.62M |
September 30, 2015 | -70.87M |
June 30, 2015 | -123.69M |
March 31, 2015 | -232.79M |
December 31, 2014 | -196.46M |
September 30, 2014 | -96.94M |
June 30, 2014 | -139.62M |
March 31, 2014 | -191.29M |
December 31, 2013 | 5.288M |
September 30, 2013 | -32.23M |
June 30, 2013 | -2.728M |
March 31, 2013 | -82.38M |
December 31, 2012 | 12.51M |
September 30, 2012 | 84.56M |
June 30, 2012 | 102.86M |
March 31, 2012 | -3.239M |
December 31, 2011 | 554.33M |
September 30, 2011 | 32.91M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-249.60M
Minimum
Jun 2021
1.228B
Maximum
Sep 2023
705.01M
Average
853.95M
Median
Free Cash Flow (Quarterly) Benchmarks
Amgen Inc | 289.00M |
Eli Lilly and Co | -1.963B |
Regeneron Pharmaceuticals Inc | 776.20M |
Moderna Inc | 402.00M |
Merck & Co Inc | -743.00M |